Marksans Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MARKSANS PHARMA, and what generic and branded alternatives to MARKSANS PHARMA drugs are available?
MARKSANS PHARMA has eighteen approved drugs.
Summary for Marksans Pharma
| US Patents: | 0 |
| Tradenames: | 15 |
| Ingredients: | 14 |
| NDAs: | 18 |
Drugs and US Patents for Marksans Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Marksans Pharma | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 090295-002 | Apr 29, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Marksans Pharma | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET;ORAL | 090888-002 | Mar 12, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Marksans Pharma | IBUPROFEN | ibuprofen | TABLET;ORAL | 090796-001 | Dec 21, 2010 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Marksans Pharma | GUAIFENESIN | guaifenesin | TABLET, EXTENDED RELEASE;ORAL | 217780-002 | Aug 21, 2023 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Marksans Pharma | FAMOTIDINE | famotidine | TABLET;ORAL | 217543-001 | Mar 8, 2023 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Marksans Pharma | DULOXETINE HYDROCHLORIDE | duloxetine hydrochloride | CAPSULE, DELAYED REL PELLETS;ORAL | 090723-001 | Dec 11, 2013 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
